NASDAQ:SPRY | Cash Flow Statement | ARS Pharmaceuticals, Inc.

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$62.34M
2026-03-31-$60.62M-$44.95M$0.00$27.79M$159,000.00
2025-12-31-$41.32M-$43.49M$0.00$24.11M$1.13M
2025-09-30-$51.15M
2025-06-30-$44.88M
2025-03-31-$33.94M-$40.74M$91,000.00$29.06M$725,000.00
2024-12-31$49.93M$42M$302,000.00-$101.76M$70.92M
2024-09-30-$19.13M
2024-06-30-$12.52M
2024-03-31-$10.29M-$6.71M$83,000.00-$8.51M$258,000.00
2023-12-31-$7.17M-$17.41M-$91,000.00$26.04M$1.81M
2023-09-30-$14.87M
2023-06-30-$17.37M
2023-03-31-$14.96M-$12.43M$193,000.00-$111.55M$1.32M
2022-12-31-$14.43M-$20.5M$126,000.00-$126,000.00$193.82M
2022-09-30-$6.58M
2022-06-30-$6.42M
2022-03-31-$7.25M-$6.93M$21,000.00-$21,000.00-$908,000.00
2021-12-31$45.78M$27.89M-$767,000.00$40.74M$52.82M
2021-09-30-$22.66M
2021-06-30-$24.5M
2021-03-31-$18.87M-$12.2M$35,000.00-$35,000.00-$128,000.00
2020-12-31-$13.09M-$11.1M$247,000.00-$247,000.00$255.4M
2020-09-30-$8.12M
2020-06-30-$6.47M
2020-03-31-$5.28M-$7.63M$33,000.00-$33,000.00$21.32M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$171.3M-$170.87M$339,000.00$56.77M$104.6M
2024-12-31$8M$13.55M$563,000.00-$106.1M$72.4M
2023-12-31-$54.37M-$59.27M$175,000.00-$87.18M$6.9M
2022-12-31-$34.68M-$40.08M$199,000.00-$199,000.00$190.73M
2021-12-31-$20.24M-$17.56M$55,000.00-$55,000.00$53.16M
2020-12-31-$32.95M-$31.2M$917,000.00-$917,000.00$408.51M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.